Omeros Corp. (OMER)
11.55
+0.11
(+0.96%)
USD |
NASDAQ |
Feb 24, 16:00
11.56
+0.01
(+0.09%)
After-Hours: 20:00
Omeros Research and Development Expense (Quarterly) : 15.76M for Sept. 30, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Edgewise Therapeutics, Inc. | 36.96M |
| Dynavax Technologies Corp. (DELISTED) | 19.12M |
| Gilead Sciences, Inc. | 1.565B |
| Merck & Co., Inc. | 3.992B |
| REGENXBIO, Inc. | 52.22M |